A pandemic that further obscures patients with rare diseases
Article Sidebar
Main Article Content
Abstract
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons
License Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
You are free to:
Share - copy and redistribute the material in any medium or format.
Adapt - remix, transform, and build upon the material The licensor cannot revoke these freedoms as long as you follow the license terms.
• Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial — You may not use the material for commercial purposes.
• ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
• No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
References
Infosalus. La pandemia ha interrumpido la atención del 90 % de personas con enfermedades raras o en busca de diagnóstico 2020 [Disponible en: https://www.infosalus.com/asistencia/noticia-pandemia-interrumpido-atencion-90-personas-enfermedades-raras-busca-diagnostico-20201013165521.html.
Leoni C, Giorgio V, Onesimo R, Tarani L, Celli M, Selicorni A, et al. The dark side of COVID-19: The need of integrated medicine for children with special care needs. Am J Med Genet A. 2020;182(8):1988-9.
Elmonem MA, Belanger-Quintana A, Bordugo A, Boruah R, Cortes-Saladelafont E, Endrakanti M, et al. The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective. Mol Genet Metab. 2020;131(3):285-8.